Download
s00125-021-05625-x.pdf 629,98KB
WeightNameValue
1000 Titel
  • A novel diabetes typology: towards precision diabetology from pathogenesis to treatment
1000 Autor/in
  1. Herder, Christian |
  2. Roden, Michael |
1000 Erscheinungsjahr 2022
1000 Publikationstyp
  1. Artikel |
1000 Online veröffentlicht
  • 2022-01-04
1000 Erschienen in
1000 Quellenangabe
  • 65(11):1770-1781
1000 Copyrightjahr
  • 2022
1000 Lizenz
1000 Verlagsversion
  • https://doi.org/10.1007/s00125-021-05625-x |
  • https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9522691/ |
1000 Publikationsstatus
1000 Sprache der Publikation
1000 Abstract/Summary
  • The current classification of diabetes, based on hyperglycaemia, islet-directed antibodies and some insufficiently defined clinical features, does not reflect differences in aetiological mechanisms and in the clinical course of people with diabetes. This review discusses evidence from recent studies addressing the complexity of diabetes by proposing novel subgroups (subtypes) of diabetes. The most widely replicated and validated approach identified, in addition to severe autoimmune diabetes, four subgroups designated severe insulin-deficient diabetes, severe insulin-resistant diabetes, mild obesity-related diabetes and mild age-related diabetes subgroups. These subgroups display distinct patterns of clinical features, disease progression and onset of comorbidities and complications, with severe insulin-resistant diabetes showing the highest risk for cardiovascular, kidney and fatty liver diseases. While it has been suggested that people in these subgroups would benefit from stratified treatments, RCTs are required to assess the clinical utility of any reclassification effort. Several methodological and practical issues also need further study: the statistical approach used to define subgroups and derive recommendations for diabetes care; the stability of subgroups over time; the optimal dataset (e.g. phenotypic vs genotypic) for reclassification; the transethnic generalisability of findings; and the applicability in clinical routine care. Despite these open questions, the concept of a new classification of diabetes has already allowed researchers to gain more insight into the colourful picture of diabetes and has stimulated progress in this field so that precision diabetology may become reality in the future.
1000 Sacherschließung
lokal Insulins [MeSH]
lokal Reclassification
lokal Humans [MeSH]
lokal Clustering
lokal Hyperglycemia [MeSH]
lokal Precision medicine
lokal Complications
lokal Diabetes Mellitus, Type 1 [MeSH]
lokal Insulin Resistance [MeSH]
lokal Comorbidity [MeSH]
lokal Review
lokal Diabetes subgroups
lokal Personalised medicine
1000 Liste der Beteiligten
  1. https://orcid.org/0000-0002-2050-093X|https://orcid.org/0000-0001-8200-6382
1000 Hinweis
  • DeepGreen-ID: c29854c8d660485ba33ad6ca94dec48e ; metadata provieded by: DeepGreen (https://www.oa-deepgreen.de/api/v1/), LIVIVO search scope life sciences (http://z3950.zbmed.de:6210/livivo), Crossref Unified Resource API (https://api.crossref.org/swagger-ui/index.html), to.science.api (https://frl.publisso.de/), ZDB JSON-API (beta) (https://zeitschriftendatenbank.de/api/), lobid - Dateninfrastruktur für Bibliotheken (https://lobid.org/resources/search)
1000 Label
1000 Dateien
1000 Objektart article
1000 Beschrieben durch
1000 @id frl:6451890.rdf
1000 Erstellt am 2023-05-12T10:36:58.030+0200
1000 Erstellt von 322
1000 beschreibt frl:6451890
1000 Zuletzt bearbeitet 2023-10-24T06:50:21.240+0200
1000 Objekt bearb. Tue Oct 24 06:50:21 CEST 2023
1000 Vgl. frl:6451890
1000 Oai Id
  1. oai:frl.publisso.de:frl:6451890 |
1000 Sichtbarkeit Metadaten public
1000 Sichtbarkeit Daten public
1000 Gegenstand von

View source